Digestive Diseases and Sciences

, Volume 26, Issue 10, pp 954–955 | Cite as

Clinical experience with monooctanoin for dissolution of bile duct stones

An uncontrolled multicenter trial
  • A. F. Hofmann
  • B. Schmack
  • J. L. Thistle
  • V. K. Babayan
Letters to the Editor

Keywords

Public Health Bile Duct Clinical Experience Bile Duct Stone Monooctanoin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Thistle JL, Carlson GL, Hofmann AF, et al.: Mono-octanoin, a dissolution agent for retained cholesterol bile duct stones: Physical properties and clinical application. Gastroenterology 78:1016–1022, 1980Google Scholar
  2. 2.
    Gadacz TR: Efficacy of Capmul and the dissolution of biliary stones. J Surg Res 26:378–380, 1979Google Scholar
  3. 3.
    Mack E, Saito C, Goldfarb S, Crummy AB, Thistle JL, Carlson GL, Babayan VK, Hoffmann AF: A new agent for gallstone dissolution: Experimental and clinical evaluation. Surg Forum 29:438–439, 1978Google Scholar
  4. 4.
    Leuschner U, Wurbs D, Landgraf H: Dissolution of biliary duct stones with mono-octanoin. Lancet 2:103–104, 1979Google Scholar
  5. 5.
    Schenk J, Schmack B, Rosch W, et al: Spulbehandlung von Choledochussteinen mit Octanoat (Capmul 8210). Dtsch Med Wochenschr 105:917–921, 1980Google Scholar

Copyright information

© Digestive Disease Systems, Inc. 1981

Authors and Affiliations

  • A. F. Hofmann
    • 1
  • B. Schmack
    • 2
  • J. L. Thistle
    • 3
  • V. K. Babayan
    • 4
  1. 1.Division of GastroenterologyUniversity of CaliforniaSan Diego
  2. 2.University Clinic University of ErlangenW. Germany
  3. 3.Mayo Clinic and FoundationRochester
  4. 4.Stokely-Van Camp Co.Indianapolis

Personalised recommendations